Cardiovascular Machine Learning Notification Software
Watches heart data for a pattern and sends an alert, without saying what the pattern means.
The general purpose entry in the cardiovascular family. These products monitor heart data and raise a flag when a learned pattern appears.
Notification is the operative word. The software gets a clinician to look. The clinician decides.
It sounds modest, and in a health system it is not. Most missed heart conditions are not missed because nobody could tell. They are missed because nobody looked at that test again.
Clearances per Year
What the FDA Actually Signed Off On
- FDA product code
- QXO
- FDA name for it
- Cardiovascular Machine Learning-Based Notification Software
- Rule number
- 21 CFR 870.2380
- Risk class
- Class 2
- Medical field
- Cardiovascular
Before You Sign Anything
- Ask who receives the alert and what they are expected to do within what time. An alert with no owner is noise.
- Ask what the alert volume looks like per thousand studies. Alarm fatigue kills these deployments faster than accuracy problems.
Who Holds the Most Clearances Here
| Company | Cleared products |
|---|---|
| Pathwai, Inc. | 1 |
| Viz. Ai, Inc. | 1 |
Every Cleared Product, Newest First
Each row links to the FDA's own record. The number in the last column is the clearance number, which is the single best thing to ask a vendor for.
Clearance data comes from the FDA's public 510(k) and device classification records through openFDA. A clearance means the FDA agreed the product is close enough to something already on the market, not that the FDA tested it in your hospital. It says nothing about accuracy in your patient mix, your scanners, or your workflow. Confirm the current status and the exact cleared indication on the FDA record before you buy.